Watchlist Price Alert

Definitive Healthcare Cor... (DH)

NASDAQ: DH · Real-Time Price · USD

3.25

-0.03 (-0.91%)

At close: May 28, 2025, 3:59 PM

3.25

0.00%

After-hours: May 28, 2025, 04:00 PM EDT

-0.91% (1D)

Bid	3.09
Market Cap	348.86M
Revenue (ttm)	247.91M
Net Income (ttm)	-510.83M
EPS (ttm)	-4.41
PE Ratio (ttm)	-0.74
Forward PE	12.63
Analyst	Hold

Ask	3.45
Volume	481,988
Avg. Volume (20D)	984,041
Open	3.29
Previous Close	3.28
Day's Range	3.18 - 3.27
52-Week Range	2.15 - 6.26
Beta	1.49

About DH

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol DH

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for DH stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

2 weeks ago

+31.32%

Definitive Healthcare shares are trading higher af... Unlock content with Pro Subscription

2 months ago

-12.38%

Definitive Healthcare shares are trading lower after Barclays cut its price target on the stock from $4 to $3.

News

2 weeks ago · seekingalpha.com

Definitive Healthcare Corp. (DH) Q1 2025 Earnings Call Transcript

Definitive Healthcare Corp. (NASDAQ:DH ) Q1 2025 - Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Matthew Ruderman - Investor Relations Kevin Coop - CEO Rick Booth - CFO Casey He...

2 weeks ago · zacks.com

Definitive Healthcare Corp. (DH) Beats Q1 Earnings and Revenue Estimates

Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.08 per share a year ago.

2 months ago · zacks.com

New Strong Sell Stocks for March 4th

Teaser: AMRC, DH and AAON have been added to the Zacks Rank #5 (Strong Sell) List on March 4, 2025.

2 months ago · seekingalpha.com

Definitive Healthcare Corp. (DH) Q4 2024 Earnings Call Transcript

Definitive Healthcare Corp. (NASDAQ:DH ) Q4 2024 Results Conference Call February 27, 2025 5:00 PM ET Company Participants Matthew Ruderman - Investor Relations Kevin Coop - Chief Executive Officer Ri...